Neelim Healthcare Consulting
Neelim

Free Dermatology mock test

25 original exam-style questions from our Dermatology bank, timed at the exam’s own pace, scored against the 65% DHA pass mark. They span 12 of the 13 blueprint domains, so you will see exactly where you are weakest - free, no sign-up.

DHA DER5421OMSB OEDPass mark DHA 65% · DOH Pass / fail only · SCFHS 65% · QCHP 65% · OMSB 65% · Kuwait MOH 65%

Free diagnosticNo sign-up · no email · results instantly

Sit 25 original exam-style questions at real exam pace

These are 25 original questions taken from our Dermatology bank, spread across 12 of the 13 domains of the published blueprint. You get 72 seconds per question, which is exactly the pace of the real DER5421 exam (30 minutes for 25). At the end you will see which domains you are weakest in, and the full worked reasoning for every question.

25
questions
30:00
time limit
65%
DHA pass mark

A short diagnostic cannot predict whether you will pass - only the real exam does that. It will show you, honestly, where you currently stand.

Quick answer

The Dermatology exam at a glance

The Dermatology licensing exam is a computer-based, multiple-choice test, and each GCC regulator sets its own. DHA, DOH, SCFHS, QCHP, OMSB and Kuwait MOH publish exact figures, listed below. This free mock gives you 25 original exam-style questions at 72 seconds each, scored against the 65% DHA pass mark, then shows your weakest domains.

Published exam figures

  • DHA

    Specialist Dermatology (DER5421)

    UAE150 MCQs3 hours

    65%

    pass mark

  • DOH

    Specialist Dermatology CBT

    UAE100 MCQs2 hours

    Pass / fail only

    pass mark

  • SCFHS

    Saudi Classification Examination - Dermatology

    Saudi Arabia200 MCQs240 minutes

    65%

    pass mark

  • QCHP

    Specialist Dermatology

    Qatar150 MCQs3 hours

    65%

    pass mark

  • OMSB

    Omani Examination for Dermatology (OED)

    Oman100 MCQs150 minutes

    65%

    pass mark

  • Kuwait MOH

    Dermatology - Registrar

    Kuwait150 MCQs170 minutes

    65%

    pass mark

Attempts in the UAE
3 in total across DHA, DOH, MOHAP and SHA
This free mock
25 questions · 30 minutes · 12 of 13 domains
Full bank
465+ questions · 3 to 6 papers · AED 319
Regulators
DHA, DOH, SCFHS, QCHP, OMSB, Kuwait MOH, MOHAP, SHA and NHRA

How this free Dermatology mock works

25
original questions
30 min
time limit
72s
per question
12 of 13
blueprint domains
  • You get 72 seconds per question, the pace of a 150-question paper in 3 hours. The timer runs in your browser and ends the sitting when it reaches zero.
  • Your score is set against the 65% DHA pass mark, the published figure for this exam. No other number is invented: there is no percentile and no pass probability.
  • At the end you see your score, your pace per question, every domain ranked weakest first, and the worked answer and source for all 25 questions.
  • You can mark each answer “sure” or “not sure”. Wrong answers you were sure about are shown first, because they are the ones you would not stop to check in the real exam.
  • Your last result is saved in your own browser only, so you can come back and compare. Nothing is sent to us.

What the real Dermatology licensing exam looks like

The Dermatology exam is a computer-based multiple-choice paper, published by 6 regulators: DHA DER5421 (pass mark 65%), DOH (pass mark Pass / fail only), SCFHS (pass mark 65%), QCHP (pass mark 65%), OMSB OED (pass mark 65%), Kuwait MOH (pass mark 65%). Every regulator's format, pass mark and fee is in the table below; confirm yours before booking.

Pass marks at a glance: exam codes and pass marks by regulator for every written exam in one sourced table.

Before you can book the exam at all you need Dataflow primary source verification of your degree, licence and experience, which typically runs several weeks. Candidates often underestimate this and end up sitting the exam sooner after study than they planned. Check where you stand with our free eligibility checker or confirm whether your title even requires an exam using the Prometric exam checker.

You get three attempts in total across all UAE authorities, not three each, under the Unified Professional Qualification Requirements. At roughly AED 1,030 per attempt, plus the licensing delay each failure adds to your visa and start date, the cost of going in underprepared is not really the exam fee.

Dermatology licensing exam in every GCC country
RegulatorExamFormatPass markFee per attempt
Specialist Dermatology (DER5421)
150 MCQs in 3 hours65%USD 280 (about AED 1,030)
DOH
Abu Dhabi, Al Ain and Al Dhafra
Practise →
Specialist Dermatology CBT
100 MCQs in 2 hoursPass / fail onlyAED 550
SCFHS
Kingdom of Saudi Arabia
Practise →
Saudi Classification Examination - Dermatology
200 MCQs in 240 minutes65%Not published
QCHP
State of Qatar
Practise →
Specialist Dermatology
150 MCQs in 3 hours65%Not published
OMSB
Sultanate of Oman
Practise →
Omani Examination for Dermatology (OED)
100 MCQs in 150 minutes65%USD 220 (about OMR 80)
Kuwait MOH
State of Kuwait
Practise →
Dermatology - Registrar
150 MCQs in 170 minutes65%Not published
MOHAP
Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah
Practise →
MOHAP licensing exam
Regulator-wide format
Computer-basedNot publishedNot published
SHA
Emirate of Sharjah
Practise →
SHA licensing exam
Regulator-wide format
Set at assessmentNot publishedNot published
NHRA
Kingdom of Bahrain
Practise →
NHRA licensing exam
Regulator-wide format
Prometric CBTNot publishedNot published

Highlighted rows publish figures for this exact Dermatology exam; the others show the regulator's general rules.

What is on the Dermatology exam: the full blueprint

The published blueprint splits into 13 domains and 235 testable sub-topics. For each one you can see its weight, how many questions this mock asks on it, and about how many the full bank holds.

  • Basic Science, Skin Biology, Cutaneous Immunology and Dermatopathology~8%

    17 sub-topics · 3 in this mock · about 38 in the full bank

    est.; DHA lists 'Basic Science'; SCFHS Part One allots 10% anatomy/structure/development, 10% innate immunity, 10% adaptive immunity, 5% keratinocytes and dermal-epidermal cohesion

  • Papulosquamous and Eczematous Dermatoses~10%

    18 sub-topics · 1 in this mock · about 47 in the full bank

    est.; DHA heading; SCFHS Final Written allots 10% to T-cell mediated inflammatory disease

  • Urticaria, Erythemas, Drug Eruptions, Purpura and Cutaneous Vasculitis~9%

    19 sub-topics · 1 in this mock · about 42 in the full bank

    est.; DHA heading 'Urticaria, Erythemas, Purpura and Connective Tissue Diseases'; SCFHS Final Written allots 10% to neutrophil/eosinophil and humoral-mediated disease

  • Vesiculobullous and Autoimmune Blistering Diseases~5%

    16 sub-topics · 1 in this mock · about 23 in the full bank

    est.; DHA heading; SCFHS Final Written allots 5%

  • Connective Tissue Disease, Dermal, Subcutaneous, Metabolic and Systemic Skin Disease~8%

    19 sub-topics · 4 in this mock · about 38 in the full bank

    est.; DHA headings 'Metabolic, Systemic Diseases and Disorders of Dermal Connective Tissues and Subcutaneous Fat' and 'Skin Manifestations of Other Diseases'; SCFHS Final Written allots 10% plus 5% metabolic/systemic

  • Cutaneous Infections, Infestations, Bites and Sexually Transmitted Infections~10%

    19 sub-topics · 4 in this mock · about 47 in the full bank

    est.; DHA heading 'Infections, Infestations and Bites'; SCFHS Final Written allots 10%

  • Cutaneous Neoplasms and Skin Cancer~9%

    18 sub-topics · 3 in this mock · about 42 in the full bank

    est.; DHA heading 'Cutaneous Neoplasms'; SCFHS allots 10% in both Part One and Final Written

  • Hair, Nail, Adnexal and Mucous Membrane Disorders~7%

    18 sub-topics · 1 in this mock · about 33 in the full bank

    est.; DHA heading 'Adnexal, Hair, Nails and Mucous Membranes Diseases'; SCFHS allots 5% hair/nail/mucosa plus 5% skin appendages

  • Pigmentary Disorders and Photodermatoses~6%

    18 sub-topics · 1 in this mock · about 28 in the full bank

    est.; DHA heading; SCFHS Final Written groups pigmentary/adnexal/physical-agent disorders at 10%, Part One allots 5% pigmentation

  • Pediatric Dermatology and Genodermatoses~8%

    18 sub-topics · not in this mock · about 38 in the full bank

    est.; DHA heading 'Pediatric Dermatology'; SCFHS Final Written allots 10% to genodermatosis and paediatric dermatology, Part One 10% genodermatosis

  • Dermatologic Therapeutics and Pharmacology~7%

    18 sub-topics · 2 in this mock · about 33 in the full bank

    est.; SCFHS Part One allots 10% to therapeutics; DHA references Wolverton Comprehensive Dermatologic Drug Therapy

  • Procedural, Surgical, Laser and Cosmetic Dermatology~8%

    19 sub-topics · 1 in this mock · about 38 in the full bank

    est.; DHA heading 'Procedural Dermatology'; SCFHS Final Written allots 10%

  • Dermatologic Emergencies, Patient Safety, Professionalism and Ethics~5%

    18 sub-topics · 3 in this mock · about 23 in the full bank

    est.; DHA lists 'Patient Safety' and 'Professionalism and Ethics' as separate coverage headings for both bands; SCFHS states these are embedded across domains

Bank counts are estimates from the published weights the bank is written to, rounded.

This mock samples 12 of 13 domains. The full bank covers all 13 across 465+ questions, including the one domain this mock does not reach.

See the full bank - AED 319

How to use your mock score

These bands are set against the 65% DHA pass mark and match the verdict on your result screen. On 25 questions, a score near the pass mark has a 95% margin of error of about ±19 points, so treat the band as a direction, not a forecast.

Below 60%

Below the line

On this sample you would likely fall short of the 65% pass mark today. Do not book yet. Start with your two weakest domains from the result, then sit full-length papers until you clear the line with room to spare.

60% to 74%

Close to the line

A few questions decide it. On a 155-question paper, every 1% is one or two questions, so drill your weakest domains and build a margin on timed papers before you book.

75% and above

On track

Clear of the pass mark on this sample. 25 questions is a small sample, so confirm it over full-length timed papers before you book: stamina and pacing fail candidates who know the material.

Getting an honest score

  1. 1Sit it cold, once. Do not look anything up. A diagnostic you help yourself through tells you nothing. The number you get is only useful if it is honest.
  2. 2Read every rationale, especially the ones you got right. Getting a question right by elimination is not the same as knowing it. The worked reasoning is free, whether or not you buy anything.
  3. 3Work on your weakest domain first. The breakdown orders your domains worst first for exactly this reason. Studying what you are already good at feels productive and moves nothing.
  4. 4Re-sit under full exam conditions later. The real paper is much longer than 25 questions and stamina matters. The full bank's 3 to 6 papers are written for exactly this.

A worked Dermatology exam question

Every question in the mock and in the paid bank is written to this standard: a clinical stem, four plausible options and the reasoning for the answer, with its source.

Hair, Nail, Adnexal and Mucous Membrane Disorders

A 62-year-old man has a single 7 mm-wide brown-black longitudinal band on the right thumbnail that has widened over 8 months, has irregular borders and variable pigment shades, and shows pigmentation extending onto the proximal nail fold and hyponychium. What is the most appropriate next step?

  1. AReassure and review in 12 months
  2. BPrescribe topical hydroquinone to the nail unit
  3. CPerform a nail matrix biopsy after nail plate avulsion to obtain a histological diagnosisCorrect
  4. DStart oral terbinafine for presumed fungal melanonychia

Why: A single, wide, rapidly evolving band with irregular borders and pigment variegation plus true Hutchinson sign (periungual pigment spread) is highly suspicious for subungual melanoma and requires a matrix biopsy for histology, since the melanocytic origin lies in the matrix. Observation risks fatal delay. Topical lightening agents do not penetrate the nail unit and delay diagnosis. Fungal melanonychia is usually associated with dystrophy and positive mycology and would not explain Hutchinson sign.

Source: Bolognia, Jorizzo & Schaffer, Dermatology, 5th ed. (2025), Nail Disorders chapter; NCCN Guidelines for Cutaneous Melanoma (2024)

Dermatology sample questions with answers

10 more original exam-style Dermatology questions, worked in full. They are not real or recalled exam questions, and none of them is in the mock above or on the bank page, so sit the mock first if you have not.

  1. Question 1 · Cutaneous Infections, Infestations, Bites and Sexually Transmitted Infections

    A registrar is calculating the LRINEC (Laboratory Risk Indicator for Necrotising Fasciitis) score for a patient with a severe soft-tissue infection. Which of the following laboratory parameters is a component of that score?

    1. ASerum albumin
    2. BSerum lactate
    3. CSerum sodium
    4. DPlatelet count
    Show answer and explanation

    Correct answer: C. Serum sodium

    The LRINEC score is built from six variables: C-reactive protein, total white cell count, haemoglobin, serum sodium, serum creatinine and serum glucose, with hyponatraemia (<135 mmol/L) scoring points. Albumin, lactate and platelet count, although often deranged in sepsis, are not part of the score. LRINEC supports but never replaces clinical judgement, and a low score does not exclude necrotising fasciitis.

    Reference: Wong CH et al. The LRINEC score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med, 2004

  2. Question 2 · Cutaneous Neoplasms and Skin Cancer

    A 54-year-old man is referred with two yellowish papules on the trunk that on histology are a sebaceous adenoma and a sebaceoma; a third lesion was reported as a keratoacanthoma with sebaceous differentiation. He had a right-sided colonic adenocarcinoma at age 46 and his sister had endometrial carcinoma at 44. Which additional investigation is most likely to confirm the underlying syndrome?

    1. ASerum alpha-fetoprotein and carcinoembryonic antigen
    2. BImmunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6, PMS2) and microsatellite instability testing on the tumour tissue, with germline testing
    3. CGermline PTEN sequencing
    4. DSkeletal survey for osteomas
    Show answer and explanation

    Correct answer: B. Immunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6, PMS2) and microsatellite instability testing on the tumour tissue, with germline testing

    Sebaceous neoplasms (adenoma, sebaceoma, sebaceous carcinoma) or keratoacanthomas with sebaceous differentiation, together with visceral malignancies of the Lynch spectrum such as right-sided colorectal and endometrial cancer, indicate Muir-Torre syndrome, the cutaneous variant of Lynch syndrome caused by germline mismatch repair mutations, most often MSH2. Loss of mismatch repair protein expression with microsatellite instability on the sebaceous tumour is the recognised screening step before germline confirmation. Tumour markers are non-diagnostic, PTEN mutation causes Cowden syndrome with trichilemmomas, and osteomas point to Gardner syndrome.

    Reference: John AM, Schwartz RA, Muir-Torre syndrome review (BJD, 2016); NCCN Genetic/Familial High-Risk Assessment: Colorectal (2024)

  3. Question 3 · Connective Tissue Disease, Dermal, Subcutaneous, Metabolic and Systemic Skin Disease

    A 44-year-old woman has hyperkeratotic, fissured, scaly lateral surfaces of the fingers, Raynaud phenomenon, inflammatory arthritis, fever and progressive dyspnoea with basal reticulation on high-resolution CT. Which single test best confirms the unifying diagnosis?

    1. AAnti-Jo-1 (and extended antisynthetase antibody panel)
    2. BAnti-cyclic citrullinated peptide antibody
    3. CPatch testing to a standard series
    4. DSerum ACE level
    Show answer and explanation

    Correct answer: A. Anti-Jo-1 (and extended antisynthetase antibody panel)

    Mechanic's hands with interstitial lung disease, arthritis, fever and Raynaud phenomenon is the antisynthetase syndrome, confirmed by antisynthetase antibodies of which anti-Jo-1 is the commonest (others include PL-7, PL-12, EJ, OJ). Anti-CCP indicates rheumatoid arthritis and would not explain mechanic's hands, patch testing addresses contact dermatitis which does not cause ILD, and serum ACE is a non-specific sarcoidosis marker with poor diagnostic performance.

    Reference: Bolognia, Jorizzo & Schaffer, Dermatology, 5th ed. (2024); Connors GR et al., antisynthetase syndrome review, Chest (2010) and subsequent ATS/ERS ILD statements

  4. Question 4 · Procedural, Surgical, Laser and Cosmetic Dermatology

    Five days after a full-thickness skin graft to the nasal tip, the graft surface is black and adherent with no surrounding erythema, warmth, fluctuance or systemic upset. What is the most appropriate management?

    1. AImmediate sharp debridement of the whole graft and re-grafting
    2. BLeave the eschar undisturbed, continue moist wound care and dressings, and review regularly until demarcation occurs
    3. CStart intravenous antibiotics and admit for observation
    4. DApply silver nitrate to the graft to hasten separation
    Show answer and explanation

    Correct answer: B. Leave the eschar undisturbed, continue moist wound care and dressings, and review regularly until demarcation occurs

    A black adherent graft at day five is usually a dry eschar of the superficial graft layers, beneath which the deeper dermal component may still take, and it also acts as a biological dressing; the correct approach is conservative moist wound care with serial review, since many such grafts heal with a good result and any true necrosis will demarcate over 2-3 weeks. Early debridement and re-grafting discards viable tissue, intravenous antibiotics are unwarranted without signs of infection, and silver nitrate is caustic and impairs re-epithelialisation.

    Reference: Robinson JK et al., Surgery of the Skin: Procedural Dermatology, 4th ed., Elsevier, 2022 (grafts and postoperative complications)

  5. Question 5 · Dermatologic Therapeutics and Pharmacology

    A 66-year-old man with a 30 pack-year smoking history and treated hypertension has severe alopecia areata and asks about an oral JAK inhibitor. Which consideration most affects the decision?

    1. AJAK inhibitors are contraindicated in anyone over 60 regardless of other factors
    2. BHis age over 65, smoking history and cardiovascular risk factors place him in the group for whom regulators advise JAK inhibitors only if no suitable alternative exists
    3. CJAK inhibitors are entirely free of thromboembolic risk in dermatological indications
    4. DOnly baseline lipids need checking; no other risk stratification is required
    Show answer and explanation

    Correct answer: B. His age over 65, smoking history and cardiovascular risk factors place him in the group for whom regulators advise JAK inhibitors only if no suitable alternative exists

    Following the ORAL Surveillance safety data, regulators advise using JAK inhibitors in patients aged 65 or older, current or past long-term smokers, and those with cardiovascular or malignancy risk factors only when no suitable alternative treatment exists, with the lowest effective dose. Age alone is not an absolute contraindication, thromboembolic and major adverse cardiovascular signals are class warnings, and monitoring extends beyond lipids to blood counts, liver function and infection and malignancy surveillance.

    Reference: EMA PRAC review of JAK inhibitors (2023); FDA boxed warning for JAK inhibitors (2021); ORAL Surveillance, N Engl J Med (2022)

  6. Question 6 · Vesiculobullous and Autoimmune Blistering Diseases

    A 72-year-old man with bullous pemphigoid has achieved clinical remission and his systemic corticosteroid is being tapered. Which investigation is most useful for monitoring disease activity and anticipating relapse during the taper?

    1. ASerial peripheral blood eosinophil counts
    2. BSerial total serum IgE levels
    3. CSerial serum anti-BP180 NC16A ELISA index values
    4. DRepeat lesional histology every three months
    Show answer and explanation

    Correct answer: C. Serial serum anti-BP180 NC16A ELISA index values

    Anti-BP180 NC16A ELISA titres correlate with disease activity in bullous pemphigoid, and persistently high or rising values at the end of treatment predict relapse, making serial ELISA the most useful monitoring tool alongside clinical scoring. Eosinophil count and total IgE are non-specific and less well correlated, and repeat histology is invasive and does not track activity.

    Reference: Borradori L et al. Updated S2k guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol 2022

  7. Question 7 · Papulosquamous and Eczematous Dermatoses

    A 34-year-old woman with severe plaque psoriasis has coexisting ileocolonic Crohn disease that is currently in remission. Methotrexate has failed and biologic therapy is planned. Which agent is least appropriate because of a recognised risk of exacerbating her bowel disease?

    1. AInfliximab
    2. BRisankizumab
    3. CSecukinumab
    4. DUstekinumab
    Show answer and explanation

    Correct answer: C. Secukinumab

    IL-17A blockade with secukinumab (and ixekizumab or brodalumab) has been associated with new-onset or flaring inflammatory bowel disease and failed in Crohn trials, so it is avoided when IBD coexists. Infliximab, ustekinumab and risankizumab are all effective in both psoriasis and Crohn disease, making them rational choices for this patient.

    Reference: Hueber et al., Gut, 2012 (secukinumab in Crohn disease); AAD-NPF guidelines for the management of psoriasis with biologics, 2019

  8. Question 8 · Urticaria, Erythemas, Drug Eruptions, Purpura and Cutaneous Vasculitis

    A 58-year-old man has recurrent lower-limb purpura worse in cold weather, arthralgia, peripheral neuropathy, low C4 with near-normal C3, and proteinuria. Which underlying condition should be excluded first?

    1. AHereditary angioedema
    2. BCoeliac disease
    3. CLatent tuberculosis
    4. DChronic hepatitis C virus infection
    Show answer and explanation

    Correct answer: D. Chronic hepatitis C virus infection

    The triad of purpura, arthralgia and weakness with neuropathy, membranoproliferative glomerulonephritis and a markedly low C4 with relatively preserved C3 is typical of mixed (type II) cryoglobulinaemic vasculitis, which is most often driven by chronic hepatitis C infection; HCV serology and RNA testing should be performed. Coeliac disease and latent tuberculosis do not produce this complement pattern, and hereditary angioedema causes non-purpuric bradykinin-mediated swelling with low C4 but no vasculitis.

    Reference: Chapel Hill Consensus Conference nomenclature (2012); Ramos-Casals et al., The cryoglobulinaemias, Lancet

  9. Question 9 · Basic Science, Skin Biology, Cutaneous Immunology and Dermatopathology

    A 4-year-old with severe atopic dermatitis has repeated episodes of impetiginised eczema with heavy Staphylococcus aureus growth, yet has no history of deep abscesses, invasive infection or delayed umbilical cord separation, and neutrophil counts and function are normal. Which mechanism best explains his cutaneous susceptibility to S. aureus?

    1. AConstitutive overproduction of cathelicidin LL-37 by keratinocytes
    2. BInherited deficiency of the terminal complement components C5 to C9
    3. CDefective neutrophil NADPH oxidase with failure of the respiratory burst
    4. DTh2 cytokines IL-4 and IL-13 suppress keratinocyte production of antimicrobial peptides such as LL-37 and human beta-defensins
    Show answer and explanation

    Correct answer: D. Th2 cytokines IL-4 and IL-13 suppress keratinocyte production of antimicrobial peptides such as LL-37 and human beta-defensins

    In atopic dermatitis the Th2 milieu, together with barrier failure, downregulates keratinocyte antimicrobial peptides (cathelicidin LL-37, human beta-defensin 2 and 3), permitting dense S. aureus colonisation and superinfection while systemic immunity remains intact. Excess LL-37 processing is characteristic of rosacea, not atopic dermatitis. Terminal complement deficiency predisposes to recurrent Neisseria infection, and NADPH oxidase deficiency causes chronic granulomatous disease with deep abscesses and granulomas, neither of which fits this clinical picture.

    Reference: Ong PY et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med, 2002; AAD guidelines of care for atopic dermatitis, 2023

  10. Question 10 · Pediatric Dermatology and Genodermatoses

    A 15-month-old boy has several firm yellow-orange domed papulonodules on the scalp and trunk that appeared over the past 6 months, and six café-au-lait macules greater than 5 mm with axillary freckling. Which additional risk should prompt specific monitoring in this child?

    1. AJuvenile myelomonocytic leukaemia
    2. BWilms tumour
    3. CHepatoblastoma
    4. DMedulloblastoma
    Show answer and explanation

    Correct answer: A. Juvenile myelomonocytic leukaemia

    The combination of multiple juvenile xanthogranulomas with neurofibromatosis type 1 is associated with an increased risk of juvenile myelomonocytic leukaemia, so periodic clinical review with attention to pallor, bleeding, organomegaly and a full blood count is warranted. Cutaneous juvenile xanthogranulomas themselves are benign and usually involute spontaneously; the important direct complication of JXG is ocular involvement with spontaneous hyphaema, which is why ophthalmology review is advised for young children with multiple lesions. Wilms tumour, hepatoblastoma and medulloblastoma are linked with other syndromes such as WAGR/Beckwith-Wiedemann, familial adenomatous polyposis and Gorlin syndrome respectively.

    Reference: Paller & Mancini, Hurwitz Clinical Pediatric Dermatology, 6th ed. (2022), chapter on Histiocytoses

Last reviewed September 2026. About these questions: every item is original, written to the published blueprint, with a rationale and a reference, and no recalled or leaked exam content is used. How we write our questions.

Free mock vs the full Dermatology bank

The mock tells you where you stand. The bank is how you close the gap.

Free Dermatology mock compared with the full bank
What you getFree mockFull bank
Questions25465+
Papers1 short timed set3 to 6 full-length papers, about 155 each
Blueprint coverage12 of 13 domainsAll 13 domains, 235 sub-topics
Worked rationaleEvery questionEvery question
ReferenceEvery questionEvery question
Timing30 minutes in your browserExam-length papers to sit against the clock
FormatOnline, freePDF sent to you, yours to keep
PriceFreeAED 319, paid once

Full Dermatology bank

Close your gaps before exam day

  • 465+ original questions in 3 to 6 full-length papers
  • A worked rationale and a reference on every question
  • Prepared for your regulator's blueprint and pass mark

One-time price

AED 319

About a third of one exam fee (about AED 1,030 per attempt)

Unlock the full bank →

No subscription · yours to keep

Frequently asked questions

Is this Dermatology mock test really free?
Yes. All 25 questions, your score, the domain breakdown and the full worked answers are free, with no sign-up, no email and no payment. The paid Dermatology bank is a separate, much larger set of 465+ questions across 3 to 6 papers at AED 319.
Are these real Dermatology exam questions?
No. They are original questions written to the published Dermatology blueprint and drawn from our full bank, not leaked or recalled items. Recalled questions breach exam security rules and are often out of date. These follow the exam's format and domain weighting.
What is the pass mark for the Dermatology exam?
By regulator: DHA DER5421 (pass mark 65%), DOH (pass mark Pass / fail only), SCFHS (pass mark 65%), QCHP (pass mark 65%), OMSB OED (pass mark 65%), Kuwait MOH (pass mark 65%), each from the regulator's own exam documents. Regulators not listed publish no figure for this exam, so confirm yours before booking. Most report only pass or fail and never release your score, which is why a diagnostic like this is useful.
How long is the Dermatology exam and how many questions?
DHA: 150 MCQs in 3 hours; DOH: 100 MCQs in 2 hours; SCFHS: 200 MCQs in 240 minutes; QCHP: 150 MCQs in 3 hours; OMSB: 100 MCQs in 150 minutes; Kuwait MOH: 150 MCQs in 170 minutes, from each regulator's own exam documents (DHA's time includes registration and the introduction, per the DHA CBT Guideline, Sep 2026). Regulators not listed publish no length for this exam, so confirm theirs in the current candidate bulletin.
What topics does the Dermatology exam cover?
The published blueprint has 13 domains and 235 testable sub-topics. The heaviest are Papulosquamous and Eczematous Dermatoses (~10%), Cutaneous Infections, Infestations, Bites and Sexually Transmitted Infections (~10%) and Urticaria, Erythemas, Drug Eruptions, Purpura and Cutaneous Vasculitis (~9%). The full domain list with weights is on this page.
How is the full Dermatology bank different from this mock?
This mock is 25 questions across 12 of the 13 blueprint domains, enough to rank your domains. The full bank is 465+ questions in 3 to 6 full-length papers of about 155 questions, covering every domain, with about 47 questions on Papulosquamous and Eczematous Dermatoses alone. Every question has a worked rationale and a reference. It costs AED 319, paid once.
What score should I aim for on this Dermatology mock?
Aim for at least 75%, which is 10 points over the 65% DHA pass mark. Below 60% you would likely fall short today; between 60% and 74% a few questions decide it. On 25 questions a score near the pass mark has a margin of error of about ±19 points, so read it as a direction.
Does passing this mock mean I will pass the real exam?
No, and we will not claim otherwise. 25 questions cannot predict a full-length paper: the margin of error is about ±19 points. What it does reliably show is which blueprint domains you are weakest in, so you know where to start.
Which regulators is this Dermatology mock for?
It is written to the shared Dermatology blueprint, so it fits DHA, DOH, SCFHS, QCHP, OMSB, Kuwait MOH, MOHAP, SHA and NHRA. DHA, DOH, SCFHS, QCHP, OMSB and Kuwait MOH publish an exam for this exact title. What changes by regulator is the length, the pass mark and the local regulation questions.
How many attempts do I get at the real exam?
In the UAE, three in total across DHA, DOH, MOHAP and SHA under the Unified Professional Qualification Requirements, not three per authority. Each attempt costs roughly AED 1,030, which is why it pays to find your weak domains first.

Other free mock exams in medicine

From a 25-question mock to the full Dermatology bank

465+ original questions in 3 to 6 full-length papers, each with a worked rationale and a reference, written to the same blueprint as the free mock on this page. One price: AED 319.